ArticleEuropean heart journal. Case reports2020
Case report: high-grade atrioventricular block in suspected COVID-19 myocarditis.
Article in European heart journal. Case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 27 citations in OpenAlex.
- COVID-19 and Cardiac Arrhythmias: Lesson Learned and Dilemmas.Journal of clinical medicine · 2024Article
- Complete heart block associated with hepatitis A infection in a female child with fatal outcome.Open medicine (Warsaw, Poland) · 2024Article
- Outcomes in patients with COVID-19 and new onset heart blocks: Insight from the National Inpatient Sample database.World journal of cardiology · 2023Article
- Noteworthy sequelae after COVID-19 pneumonia in a patient with heart failure due to cardiomyopathy.Journal of cardiology cases · 2023Article
- Conduction system disorders and electrocardiographic findings in COVID-19 deceased patients in 2021, Shiraz, Iran.World journal of cardiology · 2022Article
- COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports.Journal of clinical medicine · 2022Review
- Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020.Heart failure reviews · 2022Review
- Review
- Characteristics of bradyarrhythmia in patients with COVID-19: Systematic scoping review.Pacing and clinical electrophysiology : PACE · 2022Article
- The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury.JACC. Basic to translational science · 2022Review
- Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey.Heart rhythm · 2022Article
- [Persistent complete atrioventricular block in a young patient with COVID-19].Archivos de cardiologia de Mexico · 2022Article
- Article
- Reversible complete heart block in a patient with coronavirus disease 2019.Pacing and clinical electrophysiology : PACE · 2021Article
- A case of paroxysmal complete atrioventricular block in a COVID-19 patient.Clinical case reports · 2021Article
- Bradyarrhythmias in patients with SARS-CoV-2 infection: A narrative review and a clinical report.Pacing and clinical electrophysiology : PACE · 2021Review
- Prevalence of bradyarrhythmias needing pacing in COVID-19.Pacing and clinical electrophysiology : PACE · 2021Article
- Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms.Journal of translational autoimmunity · 2021Article
- The cardiac effects of SARS-CoV2: COVID-19 special issue.European heart journal. Case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn the ongoing pandemic of COVID-19, respiratory failure has been reported as the main cause of death in those who develop critical illness. A few cases of concurrent myocarditis have been reported, but the extent of cardiac complications with the SARS-CoV-2 strain of coronavirus is still largely unknown. CASE SUMMARY: A 53-year-old man, suspected to have COVID-19 due to a new-onset cough, shortness of breath, and hypoxia, was referred to Cardiology with sudden symptomatic bradycardia. Initial rhythm analysis revealed Type 2 atrioventricular block (Mobitz II). On arrival at the coronary care unit, he was found to be in complete heart block (Type 3). Routine blood tests showed normal electrolytes and renal function, and no elevation in troponin-I levels. Echocardiography showed mild impairment in left ventricular systolic function, with no regional wall motion abnormalities or valvular lesions. He then developed high-degree AV block lasting 6.2 s, prompting the need for an urgent permanent pacemaker implantation. DISCUSSION: Just over a third of patients with myocarditis reportedly develop a rise in cardiac troponin. Clinically suspected myocarditis can occur in the absence of a troponin rise and rarely can cause high-grade bradyarrhythmias. Myocarditis and non-specific cardiac arrhythmias have been reported in a few cases of COVID-19, but this is the first reported case of a high-grade atrioventricular conduction block with SARS-CoV-2 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.